Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines

[1]  N. Neff,et al.  Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing , 2018, Neuron.

[2]  P. Carmeliet,et al.  Defective endothelial cell migration in the absence of Cdc42 leads to capillary-venous malformations , 2018, Development.

[3]  K. Alitalo,et al.  Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms , 2018, Nature Communications.

[4]  Koji Ando,et al.  A molecular atlas of cell types and zonation in the brain vasculature , 2018, Nature.

[5]  Mayank Bansal,et al.  Dual ifgMosaic: A Versatile Method for Multispectral and Combinatorial Mosaic Gene-Function Analysis , 2017, Cell.

[6]  Michael G. Johnson,et al.  Spontaneous recombinase activity of Cre–ERT2 in vivo , 2017, Transgenic Research.

[7]  G. MacGregor,et al.  Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain , 2017, Journal of Neuroinflammation.

[8]  R. Perlman,et al.  Mouse models of human disease , 2016, Evolution, medicine, and public health.

[9]  Liqun He,et al.  Gpr116 Receptor Regulates Distinctive Functions in Pneumocytes and Vascular Endothelium , 2015, PloS one.

[10]  M. Pucéat,et al.  Msx1creERT2 knock‐In allele: A useful tool to target embryonic and adult cardiac valves , 2015, Genesis.

[11]  Spencer G. Willet,et al.  Non‐parallel recombination limits cre‐loxP‐based reporters as precise indicators of conditional genetic manipulation , 2013, Genesis.

[12]  T. Abe,et al.  Reporter Mouse Lines for Fluorescence Imaging , 2013, Development, growth & differentiation.

[13]  S. Bhattacharya,et al.  A Comparison of Exogenous Promoter Activity at the ROSA26 Locus Using a PhiC31 Integrase Mediated Cassette Exchange Approach in Mouse ES Cells , 2011, PloS one.

[14]  Alberto Smith,et al.  Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. , 2011, The Journal of clinical investigation.

[15]  M. Kiran,et al.  Changes in expression of VE-cadherin and MMPs in endothelial cells: Implications for angiogenesis , 2011, Vascular cell.

[16]  R. Adams,et al.  Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice , 2010, Nature Protocols.

[17]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[18]  A. Kulkarni,et al.  Overview: Generation of Gene Knockout Mice , 2009, Current protocols in cell biology.

[19]  Georges Lacaud,et al.  The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage , 2009, Nature.

[20]  Tian Xu,et al.  The expanding role of mouse genetics for understanding human biology and disease , 2008, Disease Models & Mechanisms.

[21]  P. Chambon,et al.  Efficient, inducible Cre‐recombinase activation in vascular endothelium , 2008, Genesis.

[22]  L. Luo,et al.  A global double‐fluorescent Cre reporter mouse , 2007, Genesis.

[23]  Nathan C Shaner,et al.  A guide to choosing fluorescent proteins , 2005, Nature Methods.

[24]  P. Chambon,et al.  A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse , 2003, Nature Biotechnology.

[25]  Colin N. Dewey,et al.  Initial sequencing and comparative analysis of the mouse genome. , 2002 .

[26]  S. Nishikawa,et al.  Definitive hematopoietic commitment within the embryonic vascular endothelial-cadherin(+) population. , 2002, Experimental hematology.

[27]  Jos Jonkers,et al.  A highly efficient ligand‐regulated Cre recombinase mouse line shows that LoxP recombination is position dependent , 2001, EMBO reports.

[28]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[29]  A. Bradley,et al.  Engineering Mouse Chromosomes with Cre-loxP: Range, Efficiency, and Somatic Applications , 2000, Molecular and Cellular Biology.

[30]  B. Sauer.  Inducible gene targeting in mice using the Cre/lox system. , 1998, Methods.

[31]  P Chambon,et al.  Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. , 1997, Biochemical and biophysical research communications.

[32]  P Chambon,et al.  Ligand-activated site-specific recombination in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Hoess,et al.  DNA specificity of the Cre recombinase resides in the 25 kDa carboxyl domain of the protein. , 1990, Journal of molecular biology.

[34]  Robert L. Perlman,et al.  Mouse models of human disease evolutionary perspective , 2016 .

[35]  S. Dymecki,et al.  Essentials of recombinase-based genetic fate mapping in mice. , 2014, Methods in molecular biology.

[36]  F. Watt,et al.  Lineage Tracing , 2012, Cell.

[37]  Sylvain Meloche,et al.  Interpreting neonatal lethal phenotypes in mouse mutants: insights into gene function and human diseases. , 2009, Physiological reviews.